Source: Medicines Authority (MT) Revision Year: 2019 Publisher: Phadisco Ltd., 185 Yiannou Kranidioti Avenue, CY-2234 Latsia, Cyprus Tel.:+357 22715000
Ceclor 125mg/5ml.
Ceclor 250mg/5ml.
| Pharmaceutical Form |
|---|
|
Granules for oral suspension. |
Each 5ml of reconstituted 125mg/5ml suspension contains, as the active ingredient, cefaclor monohydrate PhEur, equivalent to 125mg of cefaclor base.
Each 5ml of reconstituted 250mg/5ml suspension contains, as the active ingredient, cefaclor monohydrate PhEur, equivalent to 250mg of cefaclor base.
| Active Ingredient | Description | |
|---|---|---|
| Cefaclor |
Cefaclor is a second-generation cephalosporin antibiotic. Cefaclor has no activity against Pseudomonas species or Acinetobacter species. Methicillin-resistant staphylococci and most strains of enterococci (eg, Str. faecalis) are resistant to cefaclor. |
| List of Excipients |
|---|
|
125 mg/5ml and 250mg/5ml suspensions: Sucrose |
The product is filled into high density polyethylene bottles with screw caps containing 100ml of cefaclor.
Phadisco Ltd., 185 Yiannou Kranidioti Avenue, CY-2234 Latsia, Cyprus
Tel.:+357 22715000
125mg/5ml suspension: MA056/00601
250mg/5ml suspension: MA056/00602
10th November 2005
| Drug | Countries | |
|---|---|---|
| CECLOR | Austria, Australia, Brazil, Cyprus, Spain, Hong Kong, Malta, Mexico, Poland, Romania, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
